As of April 2024 Alexion Pharmaceuticals has a market cap of $40.33 Billion. This makes Alexion Pharmaceuticals the world's 473th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2021 | $40.33 B | 18.03% |
2020 | $34.17 B | 42.78% |
2019 | $23.93 B | 9.99% |
2018 | $21.75 B | -18.56% |
2017 | $26.71 B | -2.48% |
2016 | $27.39 B | -36.35% |
2015 | $43.04 B | 16.86% |
2014 | $36.83 B | 40.73% |
2013 | $26.17 B | 43.41% |
2012 | $18.25 B | 37.86% |
2011 | $13.23 B | 79.62% |
2010 | $7.36 B | 69.62% |
2009 | $4.34 B | 54.07% |
2008 | $2.82 B | -0.61% |
2007 | $2.83 B | 97.82% |
2006 | $1.43 B | 129% |
2005 | $0.62 B | -10.66% |
2004 | $0.70 B | 88.25% |
2003 | $0.37 B | 44.87% |
2002 | $0.25 B | -41.95% |
2001 | $0.44 B |